omegatherapeutics.com - OMGA Book Capitalization

Public company logo of Omega Therapeutics, Inc. (OMGA)

This chart shows that the current share price of Omega Therapeutics (OMGA) stands at 0.01. The business is currently characterized exclusively by cash burn, as the trial stage for new drugs is in its early phases and there are no stable revenue streams. Omega Therapeutics (OMGA) is pursuing global growth by scaling its digital developments. The project's objective is the systemic therapy of metabolic and oncological pathologies through the precise regulation of gene activity.

omegatherapeutics.com (OMGA) - Company Book Value from 07/04/2022 to 03/08/2025

Comprehensive metric breakdowns and analytics for Omega Therapeutics, Inc. (OMGA)

- price and consensus price forecast:
Price Rate Chart Omega Therapeutics Corp|OMGA - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Omega Therapeutics Inc|OMGA - Enterprise Value
- book capitalization data:
Equity per Share Omega Therapeutics|OMGA - Company Book Value|Capitalization to Book Value Ratio omegatherapeutics.com|OMGA - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Omega Therapeutics|OMGA - Long-Term Debt to Equity|Current Liabilities to Capital Omega Therapeutics Inc|OMGA - Company Debts|Debt to Book Value Omega Therapeutics Inc
Fundamental valuation:OMGA - Omega Therapeutics Corp
Flagship merchandise of Omega Therapeutics

The development of a diversified portfolio of epigenetic drugs across various therapeutic areas reduces risks for Omega Therapeutics (OMGA), which is reflected in the accumulation of net assets. By analyzing the dynamics of total balance sheet capital, an investor can see the real value of equity minus liabilities, allowing for a comparison with the market price to determine the fundamental discount or overvaluation of the issuer's shares.

Key competitors

TEM - Book Value of Business|QGEN: Book Capitalization|ionispharma.com (IONS) - Book Capitalization|Book Capitalization Repligen (RGEN)|Accounting Capitalization RNA|Company Book Value CRISPR Therapeutics Corp CRSP|Accounting Capitalization GeneDx Corp (WGS)|Book Capitalization RARE (Ultragenyx Pharmaceutical)|beamtx.com - Book Capitalization|SRPT (Sarepta) - Company Book Value|TWST: Total Stockholders' Equity|TXG (10x Genomics Corp) - Company Book Value|Intellia Corp (NTLA) - Company Net Assets|Book Capitalization STOK (Stoke Therapeutics)|Total Stockholders' Equity biolifesolutions.com|WVE: Book Capitalization|Book Value of Business Maze Therapeutics, Inc. (MAZE)|Book Capitalization SION (Sionna Pharma)|PRME - Book Capitalization|Company Net Assets Taysha Gene Therapies (TSHA)|uniqure.com (QURE) - Accounting Value of Company|MGTX - Company Net Assets|REGENXBIO Inc (RGNX) - Total Net Assets|SLDB - Book Capitalization|Accounting Value of Company Ocugen Pharma|Pacific Biosciences - Book Capitalization|Total Stockholders' Equity BNTC (benitec.com)|Company Book Value Design Therapeutics, Inc.|Accounting Value of Company Rocket Pharma RCKT|4D Molecular Therapeutics Inc - Book Capitalization|LXEO: Book Capitalization|Company Book Value korrobio.com (KRRO)|editasmedicine.com (EDIT) - Net Asset Value|Book Capitalization SLN (Silence Therapeutics plc)|Total Stockholders' Equity ProQR Therapeutics NV (PRQR)|Company Net Assets CDXS|Book Capitalization Sangamo BioSciences SGMO|Company Net Assets Nautilus Bio (NAUT)|Total Net Assets metagenomi.co MGX|Book Capitalization DTIL (Precision BioSciences)|GBIO - Book Valuation of Business|BOLD (Boundless Bio, Inc) - Book Capitalization|XCUR (Exicure) - Company Net Assets|IMNN: Company Book Value|Book Valuation of Business PHIO|Mustang Bio, Inc. - Company Book Value|Total Stockholders' Equity RNAZ (transcodetherapeutics.com)|Bionano Genomics - Company Book Value|Company Net Assets Applied DNA Corp APDN|Book Capitalization BLUE|IPA - Book Value of Business|OMIC: Book Capitalization|Regulus Therapeutics, Inc. (RGLS) - Book Capitalization|Book Capitalization Syros (SYRS)|Accounting Capitalization TBIO|Company Book Value TRACON Pharmaceuticals TCON|Accounting Capitalization unitybiotechnology.com (UBX)